pharmaceutical investing BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in The New England Journal of Medicine
pharmaceutical investing BioCryst Reports Agreement with PMDA on Phase 3 Clinical Trial and Regulatory Requirements for Marketing Authorization of BCX7353 in Japan
E-Power Resources Inc. Announces Flow-Through and Hard Dollar Private Placements to Fund Summer Work Program
Juggernaut Exploration: Advancing High-grade Precious Metals Assets in Northern BC’s Golden Triangle
New INNspired Article Spotlights Rare Earth Recycling as a Strategic Investment Opportunity in U.S. Critical Mineral Supply Chain
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases